Английская Википедия:Inaxaplin
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Infobox drug Inaxaplin (VX-147) is a small-molecule apolipoprotein L1 inhibitor developed by Vertex Pharmaceuticals for APOL1-mediated kidney disease. In preliminary studies the drug has shown promise in treating people with kidney disease and multiple gain of function mutations on the APOL1 gene.[1][2]
References